Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2013, Article ID 741985, 10 pages
Research Article

JNK1/2 Activation by an Extract from the Roots of Morus alba L. Reduces the Viability of Multidrug-Resistant MCF-7/Dox Cells by Inhibiting YB-1-Dependent MDR1 Expression

Laboratory of Clinical Biology and Pharmacogenomics, Department of Preventive Medicine, College of Korean Medicine, Kyung Hee University, 1 Hoegi, Dongdaemun, Seoul 130-701, Republic of Korea

Received 5 April 2013; Revised 28 June 2013; Accepted 30 June 2013

Academic Editor: Bo-Hyoung Jang

Copyright © 2013 Youn Kyung Choi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [11 citations]

The following is the list of published articles that have cited the current article.

  • Maximilian A. Seiter, Stefan Salcher, Martina Rupp, Judith Hagenbuchner, Ursula Kiechl-Kohlendorfer, Jérémie Mortier, Gerhard Wolber, Judith M. Rollinger, Petra Obexer, and Michael J. Ausserlechner, “Discovery of Sanggenon G as a natural cell-permeable small-molecular weight inhibitor of X-linked inhibitor of apoptosis protein (XIAP),” FEBS Open Bio, 2014. View at Publisher · View at Google Scholar
  • Aneta Rogalska, Agnieszka Marczak, and Barbara Bukowska, “Caspases and ROS-Dependent mechanism of action mediated by combination of WP 631 and epothilone B,” Anti-Cancer Agents in Medicinal Chemistry, vol. 14, no. 9, pp. 1261–1270, 2014. View at Publisher · View at Google Scholar
  • Xue-Bing Yan, Qing-Chao Zhu, Hong-Qi Chen, Jia-Yuan Peng, Hong-Lei Chao, Hang-Xiang Du, Zhi-Gang Wang, and Zhi-Ming Jin, “Knockdown of Y-box-binding protein-1 inhibits the malignant progression of HT-29 colorectal adenocarcinoma cells by reversing epithelial-mesenchymal transition,” Molecular Medicine Reports, vol. 10, no. 5, pp. 2720–2728, 2014. View at Publisher · View at Google Scholar
  • Li Han, Yafeng Wang, Xiaojuan Guo, Yubing Zhou, Jingmin Zhang, Ning Wang, Jinhua Jiang, Fang Ma, and Qingduan Wang, “ Downregulation of MDR1 Gene by Cepharanthine Hydrochloride Is Related to the Activation of c-Jun/JNK in K562/ADR Cells ,” BioMed Research International, vol. 2014, pp. 1–6, 2014. View at Publisher · View at Google Scholar
  • Young Hwi Kwon, Kausik Bishayee, Ataur Rahman, Jae Seung Hong, Soon-Sung Lim, and Sung-Oh Huh, “Morus alba Accumulates Reactive Oxygen Species to Initiate Apoptosis via FOXO-Caspase 3-Dependent Pathway in Neuroblastoma Cells,” Molecules and Cells, vol. 38, no. 7, pp. 630–637, 2015. View at Publisher · View at Google Scholar
  • Hyeong Sim Choi, Sung-Gook Cho, Min Kyoung Kim, Min Soo Kim, Seung Hee Moon, Il Hwan Kim, and Seong-Gyu Ko, “ Decursin in Angelica gigas Nakai (AGN) Enhances Doxorubicin Chemosensitivity in NCI/ADR-RES Ovarian Cancer Cells via Inhibition of P-glycoprotein Expression ,” Phytotherapy Research, 2016. View at Publisher · View at Google Scholar
  • Hua Wei, Jing-Jing Zhu, Xiao-Qian Liu, Wei-Hong Feng, Zhi-Min Wang, Li-Hua Yan, and John Spencer, “ Review of bioactive compounds from root barks of Morus plants (Sang-Bai-Pi) and their pharmacological effects ,” Cogent Chemistry, vol. 2, no. 1, pp. 1212320, 2016. View at Publisher · View at Google Scholar
  • Bo Yoon Chang, Seon Beom Kim, Mi Kyeong Lee, Hyun Park, and Sung Yeon Kim, “ Nonclinical Safety Assessment of Morus alba L . Fruits: Study of 90-D Toxicity in Sprague Dawley Rats and Genotoxicity in Salmonella ,” Journal of Food Science, 2016. View at Publisher · View at Google Scholar
  • Selim Demir, Ibrahim Turan, Yuksel Aliyazicioglu, Kagan Kilinc, Serap Ozer Yaman, Elif Ayazoglu Demir, Ayse Arslan, Ahmet Mentese, and Orhan Deger, “ Morus Rubra Extract Induces Cell Cycle Arrest and Apoptosis in Human Colon Cancer Cells Through Endoplasmic Reticulum Stress and Telomerase ,” Nutrition and Cancer, vol. 69, no. 1, pp. 74–83, 2016. View at Publisher · View at Google Scholar
  • Kumari Nishi, Vilwanathan Ravikumar, Vinoth Prasanna Gunasekaran, and Ganeshan Mathan, “Nuclear shuttling of Y-box binding protein 1, its clinical relevance to cancer and as a therapeutic target,” Bangladesh Journal of Pharmacology, vol. 11, no. 2, pp. 501–524, 2016. View at Publisher · View at Google Scholar
  • Toshitaka Fujihara, Yoshifumi Mizobuchi, Kohei Nakajima, Teruyoshi Kageji, Kazuhito Matsuzaki, Keiko T. Kitazato, Ryotaro Otsuka, Keijiro Hara, Hideo Mure, Toshiyuki Okazaki, Kazuyuki Kuwayama, Shinji Nagahiro, and Yasushi Takagi, “Down-regulation of MDR1 by Ad-DKK3 via Akt/NFκB pathways augments the anti-tumor effect of temozolomide in glioblastoma cells and a murine xenograft model,” Journal of Neuro-Oncology, 2018. View at Publisher · View at Google Scholar